Glenmark Pharma arm files papers for IPO with Sebi

 


Glenmark Pharma arm files papers for IPO with Sebi

 

Glenmark Pharmaceuticals on Saturday said its wholly-owned arm Glenmark Life Sciences has filed preliminary papers for an initial public offer with market regulator Sebi.

 

Glenmark Life Sciences has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (Sebi) for an initial public offer, according to a regulatory filing.

 

The offer comprises fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences Ltd, by Glenmark Pharmaceuticals Ltd, the filing said.

 

The board of directors of Glenmark Pharmaceuticals Ltd during its meeting on April 16 approved the offer for sale of up to 73,05,245 equity shares of Rs 2 apiece as part of the IPO.

 

The IPO will be subject to market conditions, receipt of applicable approvals and other considerations, the filing said.

Comments

Popular posts from this blog

KAIVALYADHAMA LAUNCHES STHAPNA PROGRAM

AET Displays to Unveil New Range of LED Products at Asia’s Broadcasting & Infotainment Show (A.B.I.S.) 202

FICCI-BAF Awards 2025 celebrates excellence in AVGC-XR Industry; Unveils FICCI-EY M&E Report on Industry Growth